Sees FY25 adjusted EBITDA between $53M-$63M. Sees FY25 free cash flow between $14M-$16M, assuming receipt of CARES Act refund in 2025. Sees new business wins ranging between $60M-$70M in FY25.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNBR: